Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

FLUPENTIXOL DIHYDROCHLORIDE CRS (100 MG)

FLUPENTIXOL DIHYDROCHLORIDE CRS (100 MG)

2413-38-9

DISCOVER
TRAMAZOLINE IMPURITY A CRS (15 MG)

TRAMAZOLINE IMPURITY A CRS (15 MG)

NA

DISCOVER
TRAMAZOLINE IMPURITY B CRS (15 MG)

TRAMAZOLINE IMPURITY B CRS (15 MG)

NA

DISCOVER
Flupentixol impurity D

Flupentixol impurity D

NA

DISCOVER
TRIHEXYPHENIDYL IMPURITY A CRS (30 MG)

TRIHEXYPHENIDYL IMPURITY A CRS (30 MG)

NA

DISCOVER
METRONIDAZOLE BENZOATE - REFERENCE SPECTRUM (N/A)

METRONIDAZOLE BENZOATE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
ISOMALTOOLIGOSACCHARIDE CRS (0.9 MG)

ISOMALTOOLIGOSACCHARIDE CRS (0.9 MG)

NA

DISCOVER
Salbutamol impurity D CRS, 10mg

Salbutamol impurity D CRS, 10mg

156339-88-7

DISCOVER
TRAMAZOLINE HYDROCHLORIDE MONOHYDRATE CRS (20 MG)

TRAMAZOLINE HYDROCHLORIDE MONOHYDRATE CRS (20 MG)

74195-73-6

DISCOVER
CETYL PALMITATE 15 CRS (60 MG)

CETYL PALMITATE 15 CRS (60 MG)

540-10-3

DISCOVER
CETYL PALMITATE 95 CRS (50 MG)

CETYL PALMITATE 95 CRS (50 MG)

540-10-3

DISCOVER
PENTOXYVERINE HYDROGEN CITRATE - REFERENCE SPECTRUM (N/A)

PENTOXYVERINE HYDROGEN CITRATE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER